Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Insulin glargine |
Is a |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|
Protamine zinc insulin |
Is a |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|
zinkinsulin med forlænget virkning |
Is a |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|
Insulin glargine (substance) |
Is a |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|
humant insulin zink suspension 100 enheder/ml injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|
insulin zink med forlænget virkning 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|
bovint insulin protamin zink 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|
langtidsvirkende insulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
1 |
bovint insulin zink suspension 100 enheder/ml injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|
bovint og porcint insulin zink suspension 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|
Insulin detemir (substance) |
Is a |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|
humant insulin zink suspension med forlænget virkning 100 enheder/ml injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
langtidsvirkende insulin |
Inferred relationship |
Some |
|